logo
Select company
Select metric
$ 18.11MNet Cash Flow - Issuance (Purchase) of Equity Shares
VS
Market
17
Sector
28
Industry
38
History
17
$ 0.57Close
$ 0.33 - $ 4.2 52-Week Range
Ticker Information

Ticker

ICU

Company Name

SEASTAR MEDICAL HOLDING CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SEASTAR MEDICAL HOLDING CORP - Net Cash Flow - Issuance (Purchase) of Equity Shares Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ICU - CF - Equity Historical data
DateNet Cash Flow - Issuance (Purchase) of Equity Shares
6/30/2025$ 18.11M
3/31/2025$ 14.47M
12/31/2024$ 17.44M
9/30/2024$ 17.04M
6/30/2024$ 8.07M
3/31/2024$ 8.18M
12/31/2023$ 6.61M
9/30/2023$ 10.19M
6/30/2023$ 10.07M
12/31/2022$ 7.04M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SEASTAR MEDICAL HOLDING CORP's latest trailing twelve months (TTM) CF - Equity stands at $ 103.53M.
  • Over the past 5 years, SEASTAR MEDICAL HOLDING CORP's average CF - Equity has been $ 16.8M.
  • The median CF - Equity for SEASTAR MEDICAL HOLDING CORP during this period was $ 10.19M
  • SEASTAR MEDICAL HOLDING CORP reached its highest CF - Equity over the past 5 years at $ 103.53M.
  • The lowest CF - Equity recorded by SEASTAR MEDICAL HOLDING CORP in the same timeframe $ -103.5M

SEASTAR MEDICAL HOLDING CORP's CF - Equity vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Equity Benchmarks
CompanyCF - Equity
RLYB : RALLYBIO CORP $ 28KLEXX : LEXARIA BIOSCIENCE CORP $ 6.05MLYRA : LYRA THERAPEUTICS INC $ 5MPULM : PULMATRIX INC $ 0LSTA : LISATA THERAPEUTICS INC $ 330KAPRE : APREA THERAPEUTICS INC $ 573.98KSONN : SONNET BIOTHERAPEUTICS HOLDINGS INC $ 7.77MBRTX : BIORESTORATIVE THERAPIES INC $ 2.05MIBIO : IBIO INC $ 3.67MERNA : ERNEXA THERAPEUTICS INC $ 5.93M

Definition of Net Cash Flow - Issuance (Purchase) of Equity Shares

[Cash Flow Statement] A component of cash flow from financing [NCFF], representing the cash inflow (outflow) from stock issuance (purchase).

ICU - Net Cash Flow - Issuance (Purchase) of Equity Shares, Last 5 years

$ -103.5M

Minimum

Jun 30, 2022

$ 103.53M

Maximum

Sep 30, 2021

$ 16.8M

Average

$ 10.19M

Median

CF - Equity Benchmark Analysis

The chart above depicts the distribution of CF - Equity for companies in the Total Stock Market. The average CF - Equity of the companies is $ 107.22K with a standard deviation of $ 17.65M.
The following table provides additional summary stats:
CF - Equity in the Market:
filtered constituents2.89K
min$ -60.59M
max$ 60.64M
average$ 107.22K
median$ 0
std$ 17.65M